Ladnaia N.N., Dementyeva L.A., Kurganova O.P., Ploskireva A.A., Pimenov N.N., Burdinskaya E.N., Yurgina O.M., Kozyrina N.V., Sokolova E.V., Chulanov V.P., Muzyka A.D., Komarova S.V., Pokrovsky V.V., Popova A.Yu., Ezhlova E.B., Igonina E.P., Akimkin V.G.
Epidemiological investigation of infection cases in children with hepatitis C virus in the Department of Hematological Oncology of the healthcare facility
|
№4 / 2022
|
Kyuregyan К.К., Isaeva О.V., Kichatova V.S., Karlsen А.А., Lopatukhina М.А., Potemkin I.А., Asadi Mobarhan F.A., Malinnikova Е.Yu., Krasnova O.G., Ivanov I.B., Rukosueva E.V., Znoyko O.O., Yushchuk N.D., Mikhailov М.I.
Prevalence of hepatitis B and C markers among the apparently healthy population of the Kaliningrad Region
|
№4 / 2020
|
Ponezheva Zh.B., Makashova V.V.
Treatment with the first Russian direct-acting antiviral drug in patients with chronic hepatitis C
|
№4 / 2019
|
Solovyev D.V., Smirnova O.A., Asratyan A.A.
Epidemiological characteristics of concomitant diseases (tuberculosis and parenteral viral hepatitides) among the population of Moscow
|
№2 / 2019
|
Batskikh S.N., Karandashova I.V., Chulanov V.P.
Current opportunities and prospects for retreatment in patients with chronic hepatitis C
|
№5 / 2017
|
Asratyan A.A., Solov’ev D.V., Smirnova O.A., Kazaryan S.M., Rusakova E.V.
Parenteral viral hepatitides and tuberculosis: Current problems of epidemiology and prevention
|
№3 / 2017
|
Salman E.R., Asatryan M.N., Gaidarenko A.D., Ershov I.F., Semenenko T.A.
Predictive assessment of preventable mortality associated with chronic hepatitis C
|
№6 / 2016
|
Ignatova T.M.
Use of telaprevir in real clinical practice
|
№3 / 2014
|
Ivanova M.R., Marzhokhova M.Yu.
Analysis of the efficiency of antiviral therapy for chronic hepatitis C
|
№4 / 2013
|
Kravchenko A.V., Kanestri V.G.
The hepatitis C virus protease inhibitor telaprevir in therapy regimens for chronic hepatitis C in patients with HIV infection
|
№2 / 2013
|
Mukomolov S.L., Levakova I.A., Sulyagina L.G., Sinaiskaya E.V., Bolsun D.D., Ivanova N.V.
Current epidemiology of hepatitis C in Russia
|
№6 / 2012
|
Sapronov G.V., Belyaeva N.M.
Possibilities of correcting interferon-induced leukopenia in patients with chronic hepatitis C
|
№4 / 2012
|